Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 19, 2026 08:30 ET | Source: Streamex Corp.

Streamex Corp. to Present at the 38th Annual ROTH Conference

WINTER PARK, Fla., March 19, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a technology and infrastructure company focused on the tokenization of commodity...
March 19, 2026 08:30 ET | Source: Quoin Pharmaceuticals, Inc.

Quoin Pharmaceuticals to Announce Corporate Update and Fourth Quarter and Full-Year 2025 Financial Results on Thursday, March 26, 2026

ASHBURN, Va., March 19, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and...
March 19, 2026 08:00 ET | Source: Grace Therapeutics, Inc.

Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences

PRINCETON, N.J., March 19, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage,...
March 19, 2026 08:00 ET | Source: Lightbridge Corporation

Lightbridge Presents Advanced Nuclear Fuel Research at TMS2026 Technical Conference

RESTON, Va., March 19, 2026 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that two of its...
March 19, 2026 08:00 ET | Source: Rezolve AI Ltd

Rezolve Ai to Showcase Production-Ready Agentic Commerce Platform at Shoptalk 2026

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), a global leader in Agentic Commerce and AI-powered retail infrastructure, today announced it will showcase its end-to-end...
March 19, 2026 08:00 ET | Source: Causeway Therapeutics Ltd

Causeway Therapeutics Presents Data from Phase 2 Clinical Trial of TenoMiR® for Lateral Epicondylitis at RNA Leaders Europe 2026

Causeway Therapeutics announces the presentation of data from its Phase 2 clinical trial evaluating TenoMiR® (CWT-001), at RNA Leaders Europe 2026.
March 19, 2026 07:30 ET | Source: Plus Therapeutics Inc.

Plus Therapeutics to Present New Analysis at ISPOR Showing CNSide® May Reduce Leptomeningeal Metastases Healthcare Costs by 40%

HOUSTON, March 19, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a healthcare company developing and commercializing precision diagnostics and...
March 19, 2026 07:30 ET | Source: Context Therapeutics Inc.

Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026

PHILADELPHIA, March 19, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging (“TCE”)...
March 19, 2026 07:30 ET | Source: Biogen Inc.

Biogen to Present New Late-Breaking Litifilimab Phase 2 AMETHYST Data in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting

Late-breaking AMETHYST Part A study results to be presented, showing safety and efficacy of litifilimab in cutaneous lupus erythematosus (CLE)Litifilimab was recently granted Breakthrough Therapy...
March 19, 2026 07:00 ET | Source: Chicago Atlantic BDC, Inc.

Chicago Atlantic BDC, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Chicago Atlantic BDC, Inc. (“LIEN” or the “Company”) (NASDAQ: LIEN), a specialty finance company that has elected to be regulated as a business...